Literature DB >> 17334649

Hippocampal damage and memory impairments as possible early brain complications of type 2 diabetes.

S M Gold1, I Dziobek, V Sweat, A Tirsi, K Rogers, H Bruehl, W Tsui, S Richardson, E Javier, A Convit.   

Abstract

AIMS/HYPOTHESIS: There is evidence that type 2 diabetes mellitus is associated with cognitive impairment. Most studies investigating this association have evaluated elderly individuals, after many years of diabetes, who generally have poor glycaemic control and significant vascular disease. The aim of the current study was to investigate the early cognitive consequences and associated brain correlates of type 2 diabetes.
MATERIALS AND METHODS: With regard to cognition and brain measures, we compared 23 age-, sex- and education-matched control subjects with 23 mostly middle-aged individuals with relatively well-controlled diabetes of less than 10 years from the time of diagnosis.
RESULTS: We found deficits in hippocampal-based memory performance and preservation of other cognitive domains. Relative to control subjects, individuals with diabetes had reductions in brain volumes that were restricted to the hippocampus. There was an inverse relationship between glycaemic control and hippocampal volume; in multivariate regression analysis, HbA(1c) was the only significant predictor of hippocampal volume, accounting for 33% of the observed variance. Other variables commonly associated with type 2 diabetes, such as elevated BMI, hypertension or dyslipidaemia, did not independently contribute to the variance in hippocampal volume. CONCLUSIONS/
INTERPRETATION: These results suggest that the medial temporal lobe may be the first brain site affected by type 2 diabetes and that individuals in poorer metabolic control may be affected to a greater extent.

Entities:  

Mesh:

Year:  2007        PMID: 17334649     DOI: 10.1007/s00125-007-0602-7

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  42 in total

Review 1.  AACE medical guidelines for clinical practice for the diagnosis and treatment of dyslipidemia and prevention of atherogenesis.

Authors:  P S Jellinger; R A Dickey; O P Ganda; A E Mehta; T T Nguyen; H W Rodbard; J A Seibel; M D Shepherd; D A Smith
Journal:  Endocr Pract       Date:  2000 Mar-Apr       Impact factor: 3.443

2.  Specific hippocampal volume reductions in individuals at risk for Alzheimer's disease.

Authors:  A Convit; M J De Leon; C Tarshish; S De Santi; W Tsui; H Rusinek; A George
Journal:  Neurobiol Aging       Date:  1997 Mar-Apr       Impact factor: 4.673

Review 3.  Neural plasticity in the ageing brain.

Authors:  Sara N Burke; Carol A Barnes
Journal:  Nat Rev Neurosci       Date:  2006-01       Impact factor: 34.870

4.  Risk for non-insulin-dependent diabetes in the normoglycaemic elderly is associated with impaired cognitive function.

Authors:  M Vanhanen; K Koivisto; L Karjalainen; E L Helkala; M Laakso; H Soininen; P Riekkinen
Journal:  Neuroreport       Date:  1997-04-14       Impact factor: 1.837

5.  Relation between body mass index and cognitive function in healthy middle-aged men and women.

Authors:  M Cournot; J C Marquié; D Ansiau; C Martinaud; H Fonds; J Ferrières; J B Ruidavets
Journal:  Neurology       Date:  2006-10-10       Impact factor: 9.910

6.  Hypertension and hypothalamo-pituitary-adrenal axis hyperactivity affect frontal lobe integrity.

Authors:  Stefan M Gold; Isabel Dziobek; Kimberley Rogers; Abdul Bayoumy; Pauline F McHugh; Antonio Convit
Journal:  J Clin Endocrinol Metab       Date:  2005-03-22       Impact factor: 5.958

7.  Reduced glucose tolerance is associated with poor memory performance and hippocampal atrophy among normal elderly.

Authors:  Antonio Convit; Oliver T Wolf; Chaim Tarshish; Mony J de Leon
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-05       Impact factor: 11.205

Review 8.  Lipid disorders in NIDDM: implications for treatment.

Authors:  M R Taskinen; U Smith
Journal:  J Intern Med       Date:  1998-11       Impact factor: 8.989

9.  MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging.

Authors:  F Fazekas; J B Chawluk; A Alavi; H I Hurtig; R A Zimmerman
Journal:  AJR Am J Roentgenol       Date:  1987-08       Impact factor: 3.959

10.  Pathological verification of ischemic score in differentiation of dementias.

Authors:  W G Rosen; R D Terry; P A Fuld; R Katzman; A Peck
Journal:  Ann Neurol       Date:  1980-05       Impact factor: 10.422

View more
  173 in total

1.  Preliminary evidence for obesity and elevations in fasting insulin mediating associations between cortisol awakening response and hippocampal volumes and frontal atrophy.

Authors:  Alexandra Ursache; William Wedin; Aziz Tirsi; Antonio Convit
Journal:  Psychoneuroendocrinology       Date:  2012-01-21       Impact factor: 4.905

2.  Cognitive impairment in nondiabetic middle-aged and older adults is associated with insulin resistance.

Authors:  H Bruehl; V Sweat; J Hassenstab; V Polyakov; A Convit
Journal:  J Clin Exp Neuropsychol       Date:  2010-06       Impact factor: 2.475

Review 3.  Metabolic Alterations Associated to Brain Dysfunction in Diabetes.

Authors:  João M N Duarte
Journal:  Aging Dis       Date:  2015-10-01       Impact factor: 6.745

Review 4.  Diabetes mellitus and cognitive impairments.

Authors:  Elham Saedi; Mohammad Reza Gheini; Firoozeh Faiz; Mohammad Ali Arami
Journal:  World J Diabetes       Date:  2016-09-15

Review 5.  Neuropathology of type 2 diabetes: a short review on insulin-related mechanisms.

Authors:  Elizabeth Guerrero-Berroa; James Schmeidler; Michal Schnaider Beeri
Journal:  Eur Neuropsychopharmacol       Date:  2014-01-30       Impact factor: 4.600

Review 6.  Magnitude of cognitive dysfunction in adults with type 2 diabetes: a meta-analysis of six cognitive domains and the most frequently reported neuropsychological tests within domains.

Authors:  Priya Palta; Andrea L C Schneider; Geert Jan Biessels; Pegah Touradji; Felicia Hill-Briggs
Journal:  J Int Neuropsychol Soc       Date:  2014-02-20       Impact factor: 2.892

7.  Reduced DNA methylation of FKBP5 in Cushing's syndrome.

Authors:  Eugenia Resmini; Alicia Santos; Anna Aulinas; Susan M Webb; Yolanda Vives-Gilabert; Olivia Cox; Gary Wand; Richard S Lee
Journal:  Endocrine       Date:  2016-09-23       Impact factor: 3.633

8.  Emotional and neutral declarative memory impairments and associated white matter microstructural abnormalities in adults with type 2 diabetes.

Authors:  Po Lai Yau; David Javier; Wai Tsui; Victoria Sweat; Hannah Bruehl; Joan C Borod; Antonio Convit
Journal:  Psychiatry Res       Date:  2009-11-10       Impact factor: 3.222

9.  Caffeine prevents weight gain and cognitive impairment caused by a high-fat diet while elevating hippocampal BDNF.

Authors:  Gregory A Moy; Ewan C McNay
Journal:  Physiol Behav       Date:  2012-12-06

Review 10.  The As and Ds of stress: metabolic, morphological and behavioral consequences.

Authors:  Lawrence P Reagan; Claudia A Grillo; Gerado G Piroli
Journal:  Eur J Pharmacol       Date:  2008-02-26       Impact factor: 4.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.